Medi-Tech Insights: Increasing preference for minimally invasive surgeries, growing adoption of single-use devices to prevent patient cross-contamination and ensure patient safety, growing cases of colorectal cancer and screening mandates in most healthcare systems, growing hospital investments in endoscopy facilities, and benefits of endoscopic procedures are some of the key factors driving the Global Gastrointestinal Endoscopic Devices market.
Brussels, Belgium, June 20, 2022 (GLOBE NEWSWIRE) --
Gastrointestinal (GI) diseases are disorders of the digestive system that involve a range of vital digestive organs such as mouth, esophagus, stomach, small and large bowels, rectum, anus, and GI connected organs (liver, gallbladder, and pancreas).
Medical devices such as endoscopes, laparoscopes/surgical endoscopes, endotherapy devices, and laparoscopic devices play a vital role in the early & accurate diagnosis and treatment of potentially life-threatening GI diseases, which in turn opens up growth avenues for GI MedTech device manufacturers.
The Resurgence of Gastrointestinal Endoscopic Devices Market Post Covid-19
Covid-19 adversely impacted health services internationally and the GI MedTech industry was no different.
Specialties such as gastroenterology were directly affected by Covid-19. The pandemic adversely impacted the workflow and safety of endoscopists, ancillary staff, and patients. Shortages of personal protective equipment (PPE), curtailed patient volume, dearth of testing kits, workforce furloughs, and lockdowns forced units to drastically reduce the volume of the procedures, postpone and even cancel GI procedures in medium- to low-risk cases. The dip in the number of GI procedures resulted in the decline of Gastrointestinal Endoscopic Devices market revenues.
However, since 2021, the Gastrointestinal Endoscopic Devices is on the recovery path. The market has been driven by the strong performance of GI MedTech companies in Japan, Europe, and North America, increased sales of gastroscopes and colonoscopes, the launch of innovative products, strong performance of the GI MedTech device manufacturers in North America, improving Covid-19 coverage globally and rising number of GI procedures.
“A price erosion in Gastrointestinal Endoscopic Devices is expected due to consolidation of group purchasing organizations (GPOs) in different markets and demand of discounts by cash-strapped hospitals in high volume purchases especially due to Covid-19 pandemic.” - Senior Director, Leading Endoscope Manufacturer, United States
Technological Advancements is driving the Gastrointestinal MedTech Devices Market
The Gastrointestinal Endoscopic Devices market is a technology-driven market and is marked by constant product enhancements/innovations. For instance,
In May, 2022, Fujifilm showcased its new endoscopy innovations for the detection, diagnosis, and treatment of diseases at Digestive Disease Week (May 21-24), 2022. The firm showcased its entire portfolio of endoscopic imaging solutions for core gastrointestinal (GI), therapeutic, interventional, and third space endoscopy including ELUXEO® VISION, G-EYE® 700 Series Colonoscopes, El-740D/S Dual-Channel Endoscope, TRACMOTION [Fujifilm’s new device for endoscopic submucosal dissection (ESD)]
“Single-use gastroscopes counter concerns related to the long waiting lists and staff shortages. Ease of setup and elimination of reprocessing are other advantages offered by the system which is expected to drive its adoption.”- Professor, Leading Hospital, United States
United States Expected to Continue to Hold a Major Share in the Gastrointestinal Endoscopic Devices Market
The United States currently holds a major share in the Global Gastrointestinal Endoscopic Devices Market. It is expected to continue to hold a major share in the coming years due to the increasing number of endoscopic examinations, rising aging population, favourable reimbursement climate for endoscopy procedures, growth in minimally invasive endoscopic therapy procedures, rising concerns over cleaning, disinfection & sterilization, and higher quality expectations.
Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold
The Global Gastrointestinal Endoscopic Devices Market is marked by the presence of both established and new players. Players operating in the Gastrointestinal MedTech Devices market adopt both organic and inorganic growth strategies such as new product launches, and partnerships to garner market share. For instance,
In February 2022 Motus GI, received FDA Clearance to market the Pure-Vu® EVS System. The new Pure-Vu EVS System improves the speed of set-up, enhances navigation capabilities in tortuous anatomy, builds upon the excellent cleansing capabilities of the Pure-Vu system and enables physicians to rapidly overcome the challenges of poorly prepared colons during a colonoscopy
The Gastrointestinal Endoscopic Devices Market is expected to continue to grow in the coming years due to growing cases of GI disorders & requirements for endoscopes, laparoscopes/surgical endoscopes, endotherapy devices, and laparoscopic devices to diagnose and treat GI disorders.
Competitive Landscape Analysis: Gastrointestinal Endoscopic Devices Market
The Gastrointestinal Endoscopic Devices market is marked by the presence of players such as Olympus, Boston Scientific, Pentax (Hoya), Fujifilm, Cook Medical, Karl Storz, Ethicon, Medtronic, Stryker, Medi-Globe, Ambu, Arthrex, Richard Wolf, ERBE, Micro-Tech, among others.
Explore Detailed Insights on Gastrointestinal Endoscopic Devices Market @ https://meditechinsights.com/gastrointestinal-endoscopic-devices-market/
About Medi-Tech Insights:
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Devices & Pharma Services.
Associate, Medi-Tech Insights
+32 498 86 80 79